Dieter Falkenburg
Directeur Général chez Novoplant GmbH
Postes actifs de Dieter Falkenburg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Directeur Général | - | - |
Historique de carrière de Dieter Falkenburg
Anciens postes connus de Dieter Falkenburg
Sociétés | Poste | Début | Fin |
---|---|---|---|
ASTA Medica Oncology | Corporate Officer/Principal | - | - |
Formation de Dieter Falkenburg
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistiques
Internationale
Allemagne | 3 |
Etats-Unis | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Process Industries | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Process Industries |
ASTA Medica Oncology |
- Bourse
- Insiders
- Dieter Falkenburg
- Expérience